Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in VYGR — Voyager Therapeutics, Inc.

CIK 73124 CHICAGO, IL
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,441,310
-$44,182 QoQ
Shares Held
411,803
+7.0% QoQ
Ownership
0.668%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 135 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 2% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. VYGR ranks #255 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in VYGR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,441,310 411,803
2026-03-31 $1,485,492 384,843
2025-12-31 $1,448,384 368,546
2025-09-30 $1,843,484 394,751
2025-06-30 $1,257,937 404,482
2025-03-31 $1,392,622 412,019
2024-12-31 $2,374,281 418,745
2024-09-30 $2,377,269 406,371
2024-06-30 $2,959,613 374,161
2024-03-31 $3,629,185 389,816
2023-12-31 $2,658,312 314,966
2023-09-30 $2,346,474 302,771
2023-06-30 $3,390,573 296,120
2023-03-31 $662,958 85,987
2022-12-31 $510,008 83,608
2022-09-30 $455,839 77,000
2022-06-30 $442,114 74,808
2022-03-31 $602,886 79,119
2021-12-31 $209,851 77,436
2021-09-30 $196,678 74,783
2021-06-30 $348,137 84,295
2021-03-31 $1,474,021 312,956
2020-12-31 $2,527,001 353,427
2020-09-30 $3,862,570 362,003
2020-06-30 $4,754,444 376,739
2020-03-31 $3,149,712 344,231